Preparing For The New Biomanufacturing Frontier: A Fireside Chat With FluGen's Andy Skibo
Source: Life Science Leader
At the Generis 2020 American Biomanufacturing Summit (July 21 – 23), Andy Skibo, chief manufacturing officer for FluGen, discusses the challenges around developing and delivering a COVID-19 vaccine on a significantly shortened timeframe, plus other opportunities for improving biomanufacturing and its supply chain to support future therapies.
This website uses cookies to ensure you get the best experience on our website. Learn more